NCT03836716

Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial

As a consequence of the results of ORARIALS-01 which did not meet any of its efficacy endpoints. The planned duration was 152 weeks. After termination, the actual mean duration of treatment was approx. 28 weeks (range approx. 2 to 71 weeks).